Microgel encapsulated nanoparticles for glucose-responsive insulin delivery

Area of Science:

• Biomaterials Science
• Endocrinology
• Drug Delivery Systems

Background:

• Self-regulating insulin delivery systems aim to improve glycemic control and prevent hypoglycemia.
• Current glucose-responsive systems face challenges in achieving rapid insulin release and long-term efficacy.
• Existing systems often struggle with desirable release kinetics, limiting their clinical applicability.

Purpose of the Study:

• To develop a glucose-responsive insulin delivery system with rapid response and sustained release properties.
• To encapsulate glucose-responsive nanoparticles within protective alginate microgels for enhanced stability and controlled release.
• To evaluate the efficacy of this novel system in a diabetic mouse model.

Main Methods:

• Development of glucose-responsive acetalated-dextran nanoparticles.
• Encapsulation of nanoparticles within porous alginate microgels.
• Assessment of insulin release kinetics and glycemic control in a streptozotocin-induced diabetic mouse model.

Main Results:

• The developed system demonstrated rapid insulin release in response to glucose fluctuations.
• Alginate microgels provided protection and stability to the nanoparticles, enabling sustained insulin release.
• The system achieved extended glycemic control in diabetic mice for 22 days with two doses.
• In vivo studies showed blood glucose reduction rates comparable to naked insulin and a healthy animal's response to a glucose challenge.

Conclusions:

• This novel glucose-responsive insulin delivery system effectively combines rapid nanoparticle response with microgel-based sustained release.
• The system shows significant potential for long-term, self-regulated glycemic management in diabetes.
• Further research may lead to advanced therapeutic strategies for diabetes treatment.